Hematology/Oncology News

A lung nodule sized 30 mm3 or greater was found in 42% of adults in Northern Europe who reported either never smoking or former smoking, according to results published in Radiology.

The biomarker-based Esopredict determined that patients with Barrett’s esophagus who were stratified as higher risk were 6.4-times more likely to progress to high-grade dysplasia or esophageal adenocarcinoma within 5 years, research showed.

Belzutifan significantly improved PFS and objective response compared with everolimus for patients with advanced renal cell carcinoma, according to results of a randomized phase 3 trial.

Revised quality indicators released by the ACG and ASGE highlight the importance of adenoma and sessile serrated lesion detection rates as well as adequate bowel preparation for improving the technical performance of colonoscopy.

Trust in health care diminished dramatically during the pandemic, and it will take multipronged interventions to restore that confidence, according to an expert.

In new guidance, the Infectious Diseases Society of America suggested that immunocompromised patients take the monoclonal antibody pemivibart as pre-exposure prophylaxis to prevent severe COVID-19.

Cognitive behavioral therapy improved mental health and quality of life for cancer survivors, according to results of a systematic review and meta-analysis.

Oregon Health & Science University has implemented a “symptom science” clinical research program designed to mitigate toxicities and improve quality of life for people with cancer.

In a final recommendation statement, the U.S. Preventative Services Task Force said there is insufficient evidence to recommend for or against the use of iron supplements during pregnancy.

The number of U.S. registered nurses, including mostly women, who planned to leave their careers lowered significantly in 2023 compared with 2022, according to updated results of the Michigan Nurse’s Study.